Pazopanib after sunitinib failure in patients with metastatic renal cell carcinoma

Juhana Rautiola; Tapio Utriainen; Katriina Peltola; Heikki Joensuu; Petri Bono

doi:10.3109/0284186X.2013.794957

Pazopanib after sunitinib failure in patients with metastatic renal cell carcinoma

Juhana Rautiola, Tapio Utriainen, Katriina Peltola, Heikki Joensuu, Petri Bono

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	Acta Oncologica
Volume	53
Issue number	1
Pages (from-to)	113-118
Number of pages	6
ISSN	0284-186X
DOIs	https://doi.org/10.3109/0284186X.2013.794957
Publication status	Published - Jan 2014
MoE publication type	A1 Journal article-refereed

Fields of Science

PHASE-III TRIAL
INTERFERON-ALPHA
SORAFENIB
SURVIVAL
EFFICACY
CANCER
SAFETY
3122 Cancers

Access to Document

10.3109/0284186X.2013.794957

Cite this

@article{df44331dc94d422a98c79b1861889850,

title = "Pazopanib after sunitinib failure in patients with metastatic renal cell carcinoma",

keywords = "PHASE-III TRIAL, INTERFERON-ALPHA, SORAFENIB, SURVIVAL, EFFICACY, CANCER, SAFETY, 3122 Cancers",

author = "Juhana Rautiola and Tapio Utriainen and Katriina Peltola and Heikki Joensuu and Petri Bono",

year = "2014",

month = jan,

doi = "10.3109/0284186X.2013.794957",

language = "English",

volume = "53",

pages = "113--118",

journal = "Acta Oncologica",

issn = "0284-186X",

publisher = "Taylor & Francis",

number = "1",

}

TY - JOUR

T1 - Pazopanib after sunitinib failure in patients with metastatic renal cell carcinoma

AU - Rautiola, Juhana

AU - Utriainen, Tapio

AU - Peltola, Katriina

AU - Joensuu, Heikki

AU - Bono, Petri

PY - 2014/1

Y1 - 2014/1

KW - PHASE-III TRIAL

KW - INTERFERON-ALPHA

KW - SORAFENIB

KW - SURVIVAL

KW - EFFICACY

KW - CANCER

KW - SAFETY

KW - 3122 Cancers

U2 - 10.3109/0284186X.2013.794957

DO - 10.3109/0284186X.2013.794957

M3 - Article

VL - 53

SP - 113

EP - 118

JO - Acta Oncologica

JF - Acta Oncologica

SN - 0284-186X

IS - 1

ER -